The Alzheimer’s Drug Discovery Foundation will host its annual fall conference on Sept. 9 to 10 in Jersey City, NJ. The conference will bring together experts and scientists to present current drug discoveries and clinical development programs, pertaining to Alzheimer’s.

Attendees will interact will professionals in the field of therapeutic development for neurodegenerative diseases and have the opportunity to network. The foundation also will introduce its ACCESS program that launched last year. It provides the scientific community with an online marketplaces of educational resources, consultants, collaborators and industry partners.

Click here to register and for more information.